Managing la malilla: Exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform.
BACKGROUND
In August 2009, Mexico reformed its drug laws and decriminalized small quantities of drugs for personal use; offenders caught three times will be mandated to enter drug treatment. However, little is known about the quality or effectiveness of drug treatment programs in Mexico. We examined injection drug users' (IDUs) experiences in drug treatment in Tijuana, Mexico, with the goal of informing program planning and policy.


METHODS
We examined qualitative and quantitative data from Proyecto El Cuete, a multi-phased research study on HIV risk among IDUs in Tijuana. Phase I consisted of 20 in-depth interviews and Phase II employed respondent-driven sampling to recruit 222 IDUs for a quantitative survey. We also reviewed national drug policy documents, surveillance data, and media reports to situate drug users' experiences within the broader sociopolitical context.


RESULTS
Participants in the qualitative study were 50% male with a mean age of 32; most injected heroin (85.0%) and methamphetamine (60.0%). The quantitative sample was 91.4% male with a mean age of 35; 98.2% injected heroin and 83.7% injected heroin and methamphetamine together. The majority of participants reported receiving treatment: residential treatment was most common, followed by methadone; other types of services were infrequently reported. Participants' perceptions of program acceptability and effectiveness were mixed. Mistreatment emerged as a theme in the qualitative interviews and was reported by 21.6% of Phase II participants, primarily physical (72.0%) and verbal (52.0%) abuse.


CONCLUSIONS
Our results point to the need for political, economic, and social investment in the drug treatment system before offenders are sentenced to treatment under the revised national drug law. Resources are needed to strengthen program quality and ensure accountability. The public health impact of the new legislation that attempts to bring drug treatment to the forefront of national drug policy should be systematically evaluated.
Syvertsen
Jennifer
J
Department of Anthropology, University of South Florida, USA.
Pollini
Robin A
RA
Lozada
Remedios
R
Vera
Alicia
A
Rangel
Gudelia
G
Strathdee
Steffanie A
SA
D000328:Adult; D003430:Cross-Sectional Studies; D003625:Data Collection; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000209:etiology; D003932:Heroin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D013287:Illicit Drugs / Q000331:legislation & jurisprudence*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000009:adverse effects; D008800:Mexico; D010342:Patient Acceptance of Health Care; D016730:Program Development; D011634:Public Health / Q000331:legislation & jurisprudence; D016320:Substance Abuse Treatment Centers; D015819:Substance Abuse, Intravenous / Q000534:rehabilitation*; D055815:Young Adult
D013287:Illicit Drugs; D008694:Methamphetamine; D003932:Heroin
Subst Use Misuse. 1999 Dec;34(14):2135-53
10573308
PLoS Med. 2008 Dec 9;5(12):e234
19071954
J Psychoactive Drugs. 2005 Sep;37(3):333-9
16295018
Drug Alcohol Depend. 2005 Sep 1;79(3):281-93
16102372
Int J Drug Policy. 2010 May;21(3):145-8
20144540
PLoS Med. 2008 Dec 9;5(12):e240
19071956
J Subst Abuse Treat. 2003 Apr;24(3):233-9
12810144
Subst Use Misuse. 2006;41(5):707-27
16603456
Psychiatry. 1975 Nov;38(4):381-7
1187897
Int J Addict. 1985 Jan;20(1):173-82
3997309
Gac Med Mex. 2009 May-Jun;145(3):189-95
19685824
West J Med. 1974 Aug;121(2):106-11
4847425
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):369-76
18176320
Am J Addict. 1999 Fall;8(4):293-9
10598212
Addiction. 2008 Jan;103(1):101-8
18028520
Subst Use Misuse. 2004;39(10-12):1907-69
15587954
Lancet. 2010 Aug 14;376(9740):493-5
20650521
Sex Transm Infect. 2009 Apr;85 Suppl 2:ii31-6
19307349
Subst Use Misuse. 2005;40(12):1777-95
16419556
AIDS. 2002 Dec;16 Suppl 3:S34-41
12685923
Addiction. 2005 Feb;100(2):150-8
15679744
Public Health Rep. 1998 Jun;113 Suppl 1:107-15
9722816
Cult Med Psychiatry. 2000 Jun;24(2):165-95
10885786
J Urban Health. 2006 Nov;83(6 Suppl):i83-97
17072761